Bioelectronics Corp (BIEL)

[srinsocal]

It should be made clear, in the Update KW said....

"The ongoing proposals with two major partners are progressing briskly, and we anticipate being able to finalize them in mid to late January"

She is referring to the Plantar Fasciitis Partner, thought to be Dr. Scholl's, and the Large Orthopedic Partner, as yet unnamed, that would generate over $2 million in 2020.

From the 12/16 Investor Update:

"Further, BioElectronics is also in discussion (under an NDA) with a global player in the orthopedic devices industry that specializes in products for rehabilitation, pain therapy, physical therapy, and surgical reconstructive implants. Our intended relationship is as an OEM supplier where, the partner would use ActiPatch technology to differentiate their line of products in the marketplace. They will contribute significant assets for promotional activities of the product, including a direct-sales team of several hundred. The initial contract proposal is for the North American territory and is expected to generate more than $2 million in sales for BioElectronics, in 2020."

This Large Orthopedic Partner is not to be confused with the Smaller Orthopedic Partner that has already signed a contract, thought to be Scott Specialties although BIEL is not allowed to publicly disclose yet, that has several ActiPatch Enhanced Products due out late in Q1.

As we saw with the Scott Specialties Deal "Finalizing" a Deal does not necessarily allow BIEL to offically name the Partner. That depends on the stipulations of each new Partner.

I hope the Partner can be named immediately after the signing but that is not under KW's control.

I do not want some claiming 'BIEL lied to us' if the terms of the Deal do not allow immediate disclosure of the Partner name.